MedTrace Logo

Proarrhythmic Medicines and Primary Cardiac Arrest

NCT00005253 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-02-10

No results posted yet for this study

Summary

To determine whether treatment with antidepressant, anticonvulsant, and antiarrhythmic drug therapies having the potential for proarrhythmia increased the risk of primary cardiac arrest. The aim of the original grant, starting in 1990 and ending in 1994, was to determine whether use of diuretics for hypertension increased the risk of primary cardiac arrest compared to the use of other antihypertensive agents.

Conditions

Sponsors & Collaborators

Principal Investigators

  • David Siscovick · University of Washington

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-01-31
Completion
2000-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005253 on ClinicalTrials.gov